Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,940
-140 (-0.99%)
Sep 10, 2024, 9:00 AM KST
-68.46%
Market Cap 310.64B
Revenue (ttm) 69.60M
Net Income (ttm) -10.43B
Shares Out 22.99M
EPS (ttm) -444.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 63,322
Open 14,100
Previous Close 14,080
Day's Range 13,900 - 14,400
52-Week Range 13,010 - 56,900
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About Vaxcell-Bio Therapeutics

Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 323990
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.